[1-[4-[[(3S)-3-hydroxy-3-[(E,2R)-6-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl]-6-oxohex-3-en-2-yl]-2-oxoindol-1-yl]methyl]phenyl]-4-oxoazetidin-2-yl] acetate

C31H35N3O7 — CID 23874419

IUPAC[1-[4-[[(3S)-3-hydroxy-3-[(E,2R)-6-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl]-6-oxohex-3-en-2-yl]-2-oxoindol-1-yl]methyl]phenyl]-4-oxoazetidin-2-yl] acetate
SMILESCC(=O)OC1CC(=O)N1c1ccc(CN2C(=O)[C@](O)([C@H](C)/C=C/CC(=O)N3CCC[C@H]3CO)c3ccccc32)cc1
InChIInChI=1S/C31H35N3O7/c1-20(7-5-11-27(37)32-16-6-8-24(32)19-35)31(40)25-9-3-4-10-26(25)33(30(31)39)18-22-12-14-23(15-13-22)34-28(38)17-29(34)41-21(2)36/h3-5,7,9-10,12-15,20,24,29,35,40H,6,8,11,16-19H2,1-2H3/b7-5+/t20-,24+,29?,31+/m1/s1
InChIKeyDSGMUHPSODRSFB-JGQPLNLZSA-N
MW561.64 g/mol
LogP2.61
Rot. Bonds9

About [1-[4-[[(3S)-3-hydroxy-3-[(E,2R)-6-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl]-6-oxohex-3-en-2-yl]-2-oxoindol-1-yl]methyl]phenyl]-4-oxoazetidin-2-yl] acetate

[1-[4-[[(3S)-3-hydroxy-3-[(E,2R)-6-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl]-6-oxohex-3-en-2-yl]-2-oxoindol-1-yl]methyl]phenyl]-4-oxoazetidin-2-yl] acetate (PubChem CID 23874419) has the molecular formula C31H35N3O7 and a molecular weight of 561.64 g/mol. Its IUPAC name is [1-[4-[[(3S)-3-hydroxy-3-[(E,2R)-6-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl]-6-oxohex-3-en-2-yl]-2-oxoindol-1-yl]methyl]phenyl]-4-oxoazetidin-2-yl] acetate.

Molecular Properties

Compound Name[1-[4-[[(3S)-3-hydroxy-3-[(E,2R)-6-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl]-6-oxohex-3-en-2-yl]-2-oxoindol-1-yl]methyl]phenyl]-4-oxoazetidin-2-yl] acetate
PubChem CID23874419
Molecular FormulaC31H35N3O7
Molecular Weight561.64 g/mol
Exact Mass561.25
IUPAC Name[1-[4-[[(3S)-3-hydroxy-3-[(E,2R)-6-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl]-6-oxohex-3-en-2-yl]-2-oxoindol-1-yl]methyl]phenyl]-4-oxoazetidin-2-yl] acetate
SMILESCC(=O)OC1CC(=O)N1c1ccc(CN2C(=O)[C@](O)([C@H](C)/C=C/CC(=O)N3CCC[C@H]3CO)c3ccccc32)cc1
InChIInChI=1S/C31H35N3O7/c1-20(7-5-11-27(37)32-16-6-8-24(32)19-35)31(40)25-9-3-4-10-26(25)33(30(31)39)18-22-12-14-23(15-13-22)34-28(38)17-29(34)41-21(2)36/h3-5,7,9-10,12-15,20,24,29,35,40H,6,8,11,16-19H2,1-2H3/b7-5+/t20-,24+,29?,31+/m1/s1
InChIKeyDSGMUHPSODRSFB-JGQPLNLZSA-N
XLogP2.61
TPSA127.69 Ų
H-Bond Donors2
H-Bond Acceptors7
Rotatable Bonds9
Heavy Atoms41
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500561.64
LogP ≤ 52.61
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 107

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'isolated_alkene', 'substructure': 'N/A'}

Analyze [1-[4-[[(3S)-3-hydroxy-3-[(E,2R)-6-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl]-6-oxohex-3-en-2-yl]-2-oxoindol-1-yl]methyl]phenyl]-4-oxoazetidin-2-yl] acetate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of [1-[4-[[(3S)-3-hydroxy-3-[(E,2R)-6-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl]-6-oxohex-3-en-2-yl]-2-oxoindol-1-yl]methyl]phenyl]-4-oxoazetidin-2-yl] acetate?
The IUPAC name of [1-[4-[[(3S)-3-hydroxy-3-[(E,2R)-6-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl]-6-oxohex-3-en-2-yl]-2-oxoindol-1-yl]methyl]phenyl]-4-oxoazetidin-2-yl] acetate (CID 23874419) is [1-[4-[[(3S)-3-hydroxy-3-[(E,2R)-6-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl]-6-oxohex-3-en-2-yl]-2-oxoindol-1-yl]methyl]phenyl]-4-oxoazetidin-2-yl] acetate.
What is the SMILES notation for [1-[4-[[(3S)-3-hydroxy-3-[(E,2R)-6-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl]-6-oxohex-3-en-2-yl]-2-oxoindol-1-yl]methyl]phenyl]-4-oxoazetidin-2-yl] acetate?
The canonical SMILES for [1-[4-[[(3S)-3-hydroxy-3-[(E,2R)-6-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl]-6-oxohex-3-en-2-yl]-2-oxoindol-1-yl]methyl]phenyl]-4-oxoazetidin-2-yl] acetate is CC(=O)OC1CC(=O)N1c1ccc(CN2C(=O)[C@](O)([C@H](C)/C=C/CC(=O)N3CCC[C@H]3CO)c3ccccc32)cc1.
What is the InChIKey of [1-[4-[[(3S)-3-hydroxy-3-[(E,2R)-6-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl]-6-oxohex-3-en-2-yl]-2-oxoindol-1-yl]methyl]phenyl]-4-oxoazetidin-2-yl] acetate?
The InChIKey is DSGMUHPSODRSFB-JGQPLNLZSA-N. The full InChI is InChI=1S/C31H35N3O7/c1-20(7-5-11-27(37)32-16-6-8-24(32)19-35)31(40)25-9-3-4-10-26(25)33(30(31)39)18-22-12-14-23(15-13-22)34-28(38)17-29(34)41-21(2)36/h3-5,7,9-10,12-15,20,24,29,35,40H,6,8,11,16-19H2,1-2H3/b7-5+/t20-,24+,29?,31+/m1/s1.
What are the key properties of [1-[4-[[(3S)-3-hydroxy-3-[(E,2R)-6-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl]-6-oxohex-3-en-2-yl]-2-oxoindol-1-yl]methyl]phenyl]-4-oxoazetidin-2-yl] acetate?
[1-[4-[[(3S)-3-hydroxy-3-[(E,2R)-6-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl]-6-oxohex-3-en-2-yl]-2-oxoindol-1-yl]methyl]phenyl]-4-oxoazetidin-2-yl] acetate has a molecular weight of 561.64 g/mol, XLogP of 2.61, 9 rotatable bonds, 2 hydrogen bond donors, and 7 hydrogen bond acceptors.
Where does this data come from?
All data for [1-[4-[[(3S)-3-hydroxy-3-[(E,2R)-6-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl]-6-oxohex-3-en-2-yl]-2-oxoindol-1-yl]methyl]phenyl]-4-oxoazetidin-2-yl] acetate is sourced from PubChem (CID 23874419), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).